Literature DB >> 8949817

Flow cytometry evaluation of the in vitro influence of four i.v. anaesthetics on respiratory burst of neutrophils.

J Heine1, M Leuwer, D Scheinichen, L Arseniev, K Jaeger, S Piepenbrock.   

Abstract

Exposure of neutrophils to anaesthetic agents may alter their functional characteristics and in patients undergoing long-term sedation this may be clinically relevant. We have investigated the in vitro influence of propofol, thiopentone, methohexitone and midazolam on phorbol 12-myristate 13-acetate (PMA)-induced respiratory burst of neutrophils by the intracellular oxidative transformation of dihydrorhodamine-123 to the fluorescent dye rhodamine-123 via flow cytometry. We tested in vitro concentrations similar to sedating, anaesthetic, 10-fold sedating and 10-fold anaesthetic plasma concentrations. All drugs showed similar inhibition of respiratory burst at sedating concentrations (1-6%). At anaesthetic concentrations, propofol produced significantly higher mean inhibition (7.3%) compared with thiopentone (4.5%) and methohexitone (0.9%). At 10-fold anaesthetic concentrations inhibition of respiratory burst by propofol was almost complete (90.8%) and significantly higher than that by thiopentone (29.2%) and methohexitone (1.8%). Methohexitone and midazolam had only minimal effects at all concentrations. The effect of the solvent of propofol (10% Intralipid) was similar to that of propofol. Thus suppression of respiratory burst of neutrophils by propofol may be caused by this lipid carrier.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949817     DOI: 10.1093/bja/77.3.387

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  10 in total

1.  Effects of propofol vs methohexital on neutrophil function and immune status in critically ill patients.

Authors:  Egbert Huettemann; Annabell Jung; Heinz Vogelsang; Nicole van Hout; Samir G Sakka
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 2.  Anesthetics, immune cells, and immune responses.

Authors:  Shin Kurosawa; Masato Kato
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

3.  Effects of Propofol and Midazolam on the Inflammation of Lungs after Intravenous Endotoxin Administration in Rats.

Authors:  Mine Gursac Celik; Ayten Saracoglu; Tolga Saracoglu; Husnu Kursad; Aysenur Dostbil; Mehmet Aksoy; Ali Ahiskalioglu; Ilker Ince
Journal:  Eurasian J Med       Date:  2015-06

4.  Thiopental inhibits migration of human leukocytes through human endothelial cell monolayers in vitro.

Authors:  R Hofbauer; D Moser; H Salfinger; M Frass; S Kapiotis
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

5.  The antiinflammatory effects of propofol in endotoxemic rats during moderate and mild hypothermia.

Authors:  Hiroko Kanakura; Takumi Taniguchi
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

6.  Benzodiazepines inhibit the rate of neutrophil apoptosis.

Authors:  Y Goto; C O'Malley; N F Fanning; J Wang; H P Redmond; G D Shorten
Journal:  Ir J Med Sci       Date:  2003 Oct-Dec       Impact factor: 1.568

7.  Effect of propofol on adhesion of activated platelets to leukocytes in human whole blood.

Authors:  Lothar de Rossi; Martina Wessiepe; Wolfgang Buhre; Ralf Kuhlen; Gabriele Hutschenreuter; Rolf Rossaint
Journal:  Intensive Care Med       Date:  2003-06-11       Impact factor: 17.440

8.  Effects of propofol on endotoxin-induced acute lung injury in rabbit.

Authors:  Sang Hyun Kwak; Jeong Il Choi; Jong Tae Park
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

9.  Protective activity of propofol, Diprivan and intralipid against active oxygen species.

Authors:  M Mathy-Hartert; G Deby-Dupont; P Hans; C Deby; M Lamy
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

10.  Impact of general anaesthesia on endoplasmic reticulum stress: propofol vs. isoflurane.

Authors:  Eun-Hye Seo; Liyun Piao; Hyun-Jun Park; Ji Yeon Lee; Mijung Sa; Chung-Sik Oh; Seung-Hyun Lee; Seong-Hyop Kim
Journal:  Int J Med Sci       Date:  2019-09-07       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.